Candida infection in critically ill patients study
Part of Infections clinical trials.
This study looks at patients in the intensive care unit who have a new infection with Candida (a type of fungus) despite taking strong antibiotics. It aims to better understand and diagnose these serious infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are in the intensive care unit (critically ill).
- You have a new sepsis infection with a fever over 100.4°F (38°C).
- You have Candida fungus found in more than one non-sterile body site.
- Your fever persists after at least 5 days of broad-spectrum antibiotics.
- You have at least one risk factor like recent abdominal surgery, pancreatitis, a central line, or receiving dialysis, steroids, or other treatments.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a shorter course of the antifungal caspofungin (7 days total) is as effective as the usual longer treatment for people with uncomplicated candidemia, a yeast infection in the blood. Participating patients must already be on caspofungin and have shown clear blood cultures for 7 days.
This study looks at how Candida infections form biofilms (protective coatings) and resist antifungal treatments. It may help find better ways to treat serious Candida infections in people with weakened immune systems or after medical procedures.
This study looks at patients in the intensive care unit who have a yeast infection in their blood (candidemia). It aims to gather information to better understand this serious condition and how to treat it.
This study looks for fungal infections in hospitalized patients. It aims to understand how common serious fungal infections are, especially in people with weakened immune systems or certain medical conditions.
This trial monitors a marker of immune function (monocyte HLA-DR) in patients with severe abdominal infections that may lead to fungal infections. It aims to see if this marker can help guide treatment.
This study looks at how having a weakened immune system affects the risk of getting infections with hard-to-treat bacteria in the ICU. Depending on your immune status, you may be placed in a group that helps doctors understand who is most at risk.
Hear when a new Invasive Candidiasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.